{"organizations": [], "uuid": "0e0866fc65c4e1ab0da369058d0a2b536708a303", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-neptune-tetra-bio-pharma-enter-co/brief-neptune-tetra-bio-pharma-enter-co-development-agreement-for-purified-cannabinoid-oil-based-products-targeting-pain-inflammation-idUSFWN1Q211R", "country": "US", "domain_rank": 408, "title": "BRIEF-Neptune, Tetra Bio-Pharma Enter Co-Development Agreement For Purified Cannabinoid Oil-Based Products Targeting Pain, Inflammation", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-12T15:10:00.000+02:00", "replies_count": 0, "uuid": "0e0866fc65c4e1ab0da369058d0a2b536708a303"}, "author": "", "url": "https://www.reuters.com/article/brief-neptune-tetra-bio-pharma-enter-co/brief-neptune-tetra-bio-pharma-enter-co-development-agreement-for-purified-cannabinoid-oil-based-products-targeting-pain-inflammation-idUSFWN1Q211R", "ord_in_thread": 0, "title": "BRIEF-Neptune, Tetra Bio-Pharma Enter Co-Development Agreement For Purified Cannabinoid Oil-Based Products Targeting Pain, Inflammation", "locations": [], "entities": {"persons": [{"name": "tetra bio-pharma", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "inflammation reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "tetra bio pharma inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 11 PM / in 7 minutes BRIEF-Neptune, Tetra Bio-Pharma Enter Co-Development Agreement For Purified Cannabinoid Oil-Based Products Targeting Pain, Inflammation Reuters Staff 1 Min Read \nFeb 12 (Reuters) - Tetra Bio Pharma Inc: \n* NEPTUNE AND TETRA BIO-PHARMA ENTER CO-DEVELOPMENT AGREEMENT FOR PURIFIED CANNABINOID OIL-BASED PRODUCTS TARGETING PAIN AND INFLAMMATION Source text for Eikon:  ", "external_links": [], "published": "2018-02-12T15:10:00.000+02:00", "crawled": "2018-02-12T15:26:27.009+02:00", "highlightTitle": ""}